People: Interleukin Genetics Inc (ILIU.PK)
26 Feb 2015
Dr. Kenneth S. Kornman, DDS, Ph.D., is President, Chief Executive Officer, Chief Scientific Officer, Director of Interleukin Genetics, Inc. He has been appointed as the Chief Executive Officer and Director of the company effective August 23, 2012. He was a member of Board of Directors from August 2006 through April 2010. Prior to founding the Company in 1986, Dr. Kornman was a Department Chairman and Professor at The University of Texas Health Center at San Antonio. He has also been a consultant and scientific researcher for many oral care and pharmaceutical companies. Dr. Kornman currently holds an academic appointment at Harvard University. He holds multiple patents in the pharmaceutical area, has published three books and more than 100 scientific papers and has lectured and consulted worldwide on the transfer of technology to clinical practice. Dr. Kornman also holds an MS (Periodontics) and Ph.D. (Microbiology-Immunology) from the University of Michigan.
|Total Annual Compensation, USD||Long-Term Incentive Plans, USD||All Other, USD||Fiscal Year Total, USD|